More stars in several galaxies combined! PSID is managed by nothing short of hucksters and they are enabled by an ineffectual and apathetic SEC who doesn't give a damn unless the company is a large cap who can afford to pay heavy fines. As a result of the inaction of SEC, PSID management basically believes they can defraud investors with impunity. On page 5 and F-19 of their last 10K filing, they mention that they entered on August 24, 2017 into an Asset Purchase Agreement where they will sell the Firefly product to ExcitePCR in exchange for 10,500,000 shares of ExcitePCR common stock. What is the value of ExcitePCR common stock? What does that mean for PSID shareholders? Why sell any part of the asset that is intended to be the single largest revenue generator for PSID?
Due to a lack of scrutiny and oversight by the corrupt SEC, PSID may think it is simply immune and can get away with fraud. I've got news for management; whether civil court or the US Attorney's office, complaints will be made and lawsuits will be filed!
